Global Molecular Epidemiology of HIV: Understanding the Genesis of AIDS Pandemic
Section snippets
Chapter Overview
Global dissemination of the Human immunodeficiency virus (HIV) represents a dramatic and deadly example of recent genome emergence and expansion. Since HIV‐1 group M began its expansion in human population roughly 70 years ago (in early twentieth century), it has been diversifying rapidly, now comprising a number of different subtypes and circulating recombinant forms (CRFs). Molecular epidemiological method has been useful tool to analyze the origin of HIVs and to track a course of global HIV
HIV Types (HIV‐1 and HIV‐2)
Etiologic agents for AIDS are subdivided into two related human retroviruses (lentiviruses): HIV‐1 (HIV type 1) and HIV‐2 (HIV type 2). HIV‐1 is distributed worldwide, accounting for the majority of HIV infections. By contrast, HIV‐2 is confined to West Africa and southern/western India (Schim van der Loeff et al., 1999). Sporadic occurrences and transmission outbreaks of HIV‐2 have been reported from many European countries (Cilla 2001, Damond 2004) and North and South America (Sullivan et al.
Global HIV‐1 Variability
On a global scale, the most prevalent HIV‐1 genotypes are subtypes C (56%), A (23%), B (8%), D (5%), and CRF01_AE (5%) in 1999 (Esparza and Bhamarapravati, 2000) (Fig. 4). The greatest genetic diversity of HIV‐1 has been found in central Sub‐Saharan Africa. Subtypes A and C are most common, but all groups and subtypes have been identified. The extensive diversification of HIV‐1 group M appears to occur within or near the DRC, where the highest diversity of group M has been recorded (Kalish 2004
Phylogenetic Sequence Analysis
For subtype classification, phylogenetic sequence analysis is the most reliable method. Various software programs for phylogenetic analysis (i.e., molecular evolutionary genetic analysis, MEGA) are freely available (http://hiv‐web.lanl.gov/). Due to the high frequency of recombination in HIV, it is necessary to equip software programs designed for identifying recombination. This is particularly the case for the molecular epidemiological investigation in the areas where different lineages of
HIV/AIDS as a “Zoonosis”
Current evidence indicates that HIV‐1 and HIV‐2 entered into human population through multiple zoonotic infections from SIVs‐infected nonhuman primates (Hahn et al., 2000). It has been known that HIV‐2 and SIV sm have a high degree of genetic and phenotypic homology (Gao et al., 1992), sharing unique open‐reading frame, called vpx, in their genomes. Moreover, the habitat of the sooty mangabey closely matches HIV‐2 endemicity in West Africa. These close relationships between HIV‐2 and SIV‐sm led
HIV‐1 Subtypes and Disease Progression
It has been suggested that HIV‐1 subtypes could influence viral transmissibility and pathogenecity. However, the existence of many other factors makes it difficult to establish the true effect of viral subtypes. A study in Thailand showed that the disease progression in the patients infected with CRF01_AE is similar to those observed in subtype B‐infected populations in the West (Amornkul 1999, Kilmarx 2000).
In contrast, several studies showed that HIV‐1 subtypes differ in rates of progression
Conclusions
Global dissemination of HIVs represents a dramatic and deadly example of recent genome emergence and expansion. As reviewed in this chapter, recent studies revealed that a pandemic HIV strain, HIV‐1 group M, began its expansion in human population roughly 70 years ago (early twentieth century), it has been diversifying rapidly, now comprising a number of different subtypes and CRFs, and that new recombinant strains are arising continually, becoming a powerful force in global HIV‐1 spread.
Acknowledgments
We thank Tee Kok Keng, Shigeru Kusagawa, and Midori Kawasaki for assistance with the manuscript and references, and Drs. Kuan‐Teh Jeang and Naoki Yamamoto for their encouragement and advice. We acknowledge grant support from Ministry of Health, Labour and Welfare, Ministry of Education, Science and Technology in Japan and Japanese Foundation for AIDS Prevention. We also thank our collaborators and colleagues in Asia.
References (97)
- et al.
HIV‐1 LTR subtype and perinatal transmission
Virology
(2001) - et al.
Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants
Virology
(1998) - et al.
Isolation and envelope sequence of a highly divergent HIV‐1 isolate: Definition of a new HIV‐1 group
Virology
(1994) - et al.
Accelerating the development and future availability of HIV‐1 vaccines: Why, when, where, and how?
Lancet
(2000) - et al.
African HIV‐1 subtype C and rate of progression among Ethiopian immigrants in Israel
Lancet
(1997) - et al.
Dual HIV‐1 infection associated with rapid disease progression
Lancet
(2004) Difficulties and strategies of HIV diagnosis
Lancet
(1996)- et al.
Slower heterosexual spread of HIV‐2 than HIV‐1
Lancet
(1994) - et al.
HIV‐1 sequence variation: Drift, shift, and attenuation
Cell
(2001) - et al.
Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria
Virology
(1999)
Independent introduction of two major HIV‐1 genotypes into distinct high‐risk populations in Thailand
Lancet
Similar rate of disease progression among individuals infected with HIV‐1 genetic subtypes A‐D
AIDS
HIV‐1 superinfection despite broad CD8+ T‐cell responses containing replication of the primary virus
Nature
Clinical disease associated with HIV‐1 subtype B′ and E infection among 2104 patients in Thailand
AIDS
Sequence specificity of the human immunodeficiency virus type 2 (HIV‐2) long terminal repeat 3 region in vivo allows subtyping of the principal HIV‐2 viral subtypes A and B
AIDS Res. Hum. Retroviruses
Identification of a novel HIV‐1 circulating ADG intersubtype recombinant form (CRF19_cpx) in Cuba
J. Acquir. Immune Defic. Syndr.
Molecular evidence of homosexual transmission of HIV type 2 in Spain
AIDS Res. Hum. Retroviruses
env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area
J. Virol.
High HIV‐1 genetic diversity in Cuba
AIDS
Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification
AIDS Res. Hum. Retroviruses
Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west‐central African origin
J. Virol.
Identification of a newly characterized HIV‐1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype‐like virion structure
J. Acquir. Immune Defic. Syndr.
Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV‐1 env genes
Science
Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group
J. Virol.
Molecular epidemiology of HIV type 1 infection in Portugal: High prevalence of non‐B subtypes
AIDS Res. Hum. Retroviruses
Recombination following superinfection by HIV‐1
AIDS
Human infection by genetically diverse SIVSM‐related HIV‐2 in west Africa
Nature
Origin of HIV‐1 in the chimpanzee Pan troglodytes troglodytes
Nature
Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person‐years of observation
J. Infect. Dis.
Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV‐1 and HIV‐2) mixed infections in India reveals a recent spread of HIV‐1 and HIV‐2 from a single ancestor for each of these viruses
J. Virol.
A new subtype of human immunodeficiency virus type 1 (MVP‐5180) from Cameroon
J. Virol.
AIDS as a zoonosis: Scientific and public health implications
Science
High proportion of unrelated HIV‐1 intersubtype recombinants in the Mbeya region of southwest Tanzania
AIDS
Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C
J. Infect. Dis.
A patient with HIV‐1 superinfection
N. Engl. J. Med.
Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV‐1‐positive persons in Uganda
J. Infect. Dis.
The evolving molecular epidemiology of HIV‐1 envelope subtypes in injecting drug users in Bangkok, Thailand: Implications for HIV vaccine trials
AIDS
Recombinant viruses and early global HIV‐1 epidemic
Emerg. Infect. Dis.
Human immunodeficiency virus type 1 subtypes differ in disease progression
J. Infect. Dis.
Disease progression and survival with human immunodeficiency virus type 1 subtype E infection among female sex workers in Thailand
J. Infect. Dis.
Introduction of human immunodeficiency virus 2 infection into South Korea
Acta Virol.
Timing the ancestor of the HIV‐1 pandemic strains
Science
Genetic and serologic characterization of HIV type 1 prevailing in Myanmar (Burma)
AIDS Res. Hum. Retroviruses
Identification of HIN type 2 subtype B transmission in East Africa
AIDS Res. Hum. Retroviruses
Tracing the origin and history of the HIV‐2 epidemic
Proc. Natl. Acad. Sci. USA
HIV‐1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad
AIDS
Full‐length human immunodeficiency virus type 1 genomes from subtype C‐infected seroconverters in India, with evidence of intersubtype recombination
J. Virol.
Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France
J. Virol.
Cited by (24)
Vitamin D immunomodulatory role in chronic and acute viral diseases
2019, Emerging and Reemerging Viral Pathogens: Volume 1: Fundamental and Basic Virology Aspects of Human, Animal and Plant PathogensOverview of HIV molecular epidemiology among people who inject drugs in Europe and Asia
2016, Infection, Genetics and EvolutionCitation Excerpt :Group M strains are classified into nine genetically distinct subtypes (A–D, F–H, J, K), sub-subtypes (A1, A2, F1, F2), circulating recombinant forms (CRFs) that have been detected in at least three epidemiologically unlinked individuals, and unique recombinant forms (URFs) (Peeters et al., 2013). Based on global estimates for 2000–2007, subtype B is dominant in Western and Central Europe, Australia, and the Americas but represents around 11% of all circulating strains (Hemelaar et al., 2011; Takebe et al., 2004, 2008). Approximately half (48%) of the HIV-1-infected population carries subtype C, which is prevalent in southern Africa and India (Abecasis et al., 2013; Hemelaar et al., 2011; Takebe et al., 2004, 2008).
An integrated chip capable of performing sample pretreatment and nucleic acid amplification for HIV-1 detection
2013, Biosensors and BioelectronicsCitation Excerpt :HIV can be divided into two major types: HIV-1 and HIV-2. HIV-1 is the predominant strain circulating around the world, while HIV-2 is rarely seen outside of Africa (Takebe et al., 2008). HIV-1 can be further divided into three distinct groups-major (M), outlier (O), and new (N) groups (Ayouba et al., 2000; Buonaguro et al., 2007; Gurtler et al., 1994; Simon et al., 1998).
Global Epidemiology of Sexually Transmitted Diseases
2013, Sexually Transmitted DiseasesGlobal Epidemiology of Sexually Transmitted Diseases
2012, Sexually Transmitted Diseases: Vaccines, Prevention, and ControlAssessment of phylogenetic sensitivity for reconstructing HIV-1 epidemiological relationships
2012, Virus ResearchCitation Excerpt :Phylogenetic sensitivity for reconstructing epidemiological relationships was assessed in multiple HIV-1 datasets in pol gene (protease, PR and partial reverse transcriptase, RT), using different phylogenetic methods. The latter region was selected due to its extensive availability from HIV-1 genotyping resistance testing, thus providing the most extensively used region for molecular epidemiology studies of the global HIV-1 epidemic (Anon., 2008; Grenfell et al., 2004; Hemelaar et al., 2011; McCutchan, 2006; Paraskevis et al., 2009; Pybus and Rambaut, 2009; Rambaut et al., 2004; Takebe et al., 2008; Taylor et al., 2008; Thomson and Najera, 2005; Vercauteren et al., 2009; Woodman and Williamson, 2009). The pol gene has been suggested to contain sufficient variability for reconstruction of epidemiological linkage through phylogenetic analysis (Hue et al., 2004) against other more diverse genes.